Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F12%3A43906592" target="_blank" >RIV/00216208:11120/12:43906592 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00023752:_____/12:43913773
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls
Popis výsledku v původním jazyce
Background: Inflammatory immune processes have been clearly implicated in the etiopathology of schizophrenia. There are, however, only limited data dealing with immune parameters in the first episode patients with schizophrenia and the course of these parameters during treatment. Subjects and Methods: The presented study compared plasma levels of interleukin (IL)-6, IL-8, IL-10 and TNF-alpha in 25 patients with the first episode of schizophrenia with the minimal exposition of antipsychotics before and after treatment and with age and sex matched group of healthy volunteers. Changes in plasma cytokine levels were investigated after 4 weeks of treatment in relationship with the therapeutic outcome. Results: Our results show significantly increased plasmalevels of IL-6 (p <= 0.001) and TNF-alpha (p <= 0.001) in patients at the admission in comparison with healthy volunteers. After 4 weeks of the treatment the PANSS score decreased (p <= 0.001), concurrently the plasma level of IL-6 decre
Název v anglickém jazyce
Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls
Popis výsledku anglicky
Background: Inflammatory immune processes have been clearly implicated in the etiopathology of schizophrenia. There are, however, only limited data dealing with immune parameters in the first episode patients with schizophrenia and the course of these parameters during treatment. Subjects and Methods: The presented study compared plasma levels of interleukin (IL)-6, IL-8, IL-10 and TNF-alpha in 25 patients with the first episode of schizophrenia with the minimal exposition of antipsychotics before and after treatment and with age and sex matched group of healthy volunteers. Changes in plasma cytokine levels were investigated after 4 weeks of treatment in relationship with the therapeutic outcome. Results: Our results show significantly increased plasmalevels of IL-6 (p <= 0.001) and TNF-alpha (p <= 0.001) in patients at the admission in comparison with healthy volunteers. After 4 weeks of the treatment the PANSS score decreased (p <= 0.001), concurrently the plasma level of IL-6 decre
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FL - Psychiatrie, sexuologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NT13843" target="_blank" >NT13843: Vliv imunitní dysregulace a latentní toxoplazmózy na morfologické změny mozku u schizofrenie: animální modely a prospektivní volumometrická studie u pacientů.</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2012
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Psychiatria Danubina
ISSN
0353-5053
e-ISSN
—
Svazek periodika
24
Číslo periodika v rámci svazku
Suppl. 1
Stát vydavatele periodika
HR - Chorvatská republika
Počet stran výsledku
4
Strana od-do
"S153"-"S156"
Kód UT WoS článku
000309094600035
EID výsledku v databázi Scopus
—